Top of the morning to you, and a fine one it is. Although quite chilly so far, the clear, blue skies and warm sunshine are a heartening elixir for a busy day ahead. To cope, we are brewing fresh cups of stimulation. Our choice today is chocolate raspberry. As always you are invited to join us. Meanwhile, here are a few items of interest to get you started on your own journey, which we hope will be informative and exciting. Keep in touch, everyone …

Eli Lilly’s next-generation obesity drug led to what appears to be the most weight loss seen so far in a late-stage trial, but rates of side effects were high and many participants discontinued the treatment, including people who felt they were losing too much weigh t, STAT writes. In a 68-week Phase 3 study of patients with obesity and knee

See Full Page